Frontlight ResearchEarly access
Trial site
Guangxi Medical University Cancer hospital & Guangxi Cancer Institute
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Brain metastases1 trial
- Diffuse large B-cell lymphoma1 trial
- Lung cancer1 trial
- Phase
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Allist Pharmaceuticals, Inc.1 trial
- Genfleet Therapeutics (Shanghai) Inc.1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
Running trials
Recruiting
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Lung cancer1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026